Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-30

FDA Approved: NITROFURANTOIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a generic nitrofurantoin product (nitrofurantoin monohydrate/macrocrystals) under an Original Application (ANDA209225) from Aurobindo Pharma Limite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))